HYPR Stock Analysis: Buy, Sell, or Hold?
HYPR - Hyperfine, Inc. Class A Common Stock
$1.13
0.04 (3.67%)
▲
5d:
+0.89%
30d:
+2.73%
90d:
+15.39%
BUY
HIGH Confidence
Analysis Updated: Apr 2, 2026 12:00 AM ET
Earnings: May 12, 2026
Smart Money Accumulation
HYPR is down 3.6% this week, but smart money is accumulating calls. Top strike: $1.5 2026-04-17 with 681 OI. Call ratio: 77% View Scanner →
Strength: 4.5/10
Get Alerted When HYPR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HYPR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HYPR shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: HYPR is currently trading at $1.13, which is considered fair relative to its 30-day fair value range of $1.08 to $1.20.
Technical Outlook: Technically, HYPR is in a uptrend. Immediate support is located at $1.03, while resistance sits at $1.27. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.05 (+81.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HYPR is in a uptrend. Immediate support is located at $1.03, while resistance sits at $1.27. The stock is showing strong short-term momentum, up 3.7% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $2.05 (+81.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$1.08 -
$1.20
Company Quality Score
49/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.0%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.7%)
- BULLISH: Trading 81.4% below Wall St target ($2.05)
Fair Price Analysis
30-Day Fair Range
$1.08 -
$1.20
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$1.03
Resistance Level
$1.28
Current Trend
Uptrend
Technical data as of
Apr 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.42
Wall Street Target
$2.05
(+81.4%)
Revenue Growth (YoY)
128.0%
Profit Margin
-262.3%
Share & Embed Analysis
Last updated: April 03, 2026 4:58 AM ET
Data refreshes hourly during market hours. Next update: 5:58 AM
Data refreshes hourly during market hours. Next update: 5:58 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HYPR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Thomas Teisseyre
SELL
1405 shares
2025-11-19
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$424 | 61 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$133 | 59 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$111 | 62 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$96 | 56 HOLD |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$93 | 62 BUY |
Advanced HYPR Option Strategies
Professional options setups generated by AI based on today's HYPR price and gamma walls.
